These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1128746)

  • 21. [Selection criteria for radical prostatectomy with reference to long-term results].
    Frohmüller H; Wirth M; Manseck A; Theiss M
    Urologe A; 1991 Nov; 30(6):394-400. PubMed ID: 1771718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
    BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
    Noguchi M; Stamey TA; Neal JE; Yemoto CE
    J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prostate cancer].
    Shimazaki J; Isaka S; Akakura K; Akimoto S; Morita S
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2092-7. PubMed ID: 9388518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radical retropubic prostatectomy].
    Katz R; Shapiro A; Meretyk S; Landau EH; Pode D
    Harefuah; 1997 Aug; 133(3-4):87-91, 168. PubMed ID: 9332069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometric and clinical studies on 68 consecutive radical prostatectomies.
    Stamey TA; McNeal JE; Freiha FS; Redwine E
    J Urol; 1988 Jun; 139(6):1235-41. PubMed ID: 3373594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motion picture: transpubic total prostatectomy.
    Robson CJ
    Trans Am Assoc Genitourin Surg; 1976; 68():23. PubMed ID: 1030547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease.
    Larsen MP; Carter HB; Epstein JI
    J Urol; 1991 Oct; 146(4):1059-63. PubMed ID: 1895422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma.
    Middleton RG; Smith JA; Melzer RB; Hamilton PE
    J Urol; 1986 Aug; 136(2):422-4. PubMed ID: 3735507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic lymph node status as predictor of extracapsular tumor extension in clinical stage B prostatic cancer.
    Catalona WJ; Fleischmann J; Menon M
    J Urol; 1983 Feb; 129(2):327-9. PubMed ID: 6834499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical results of radical surgery for prostate cancer].
    Morioka M; Watanabe H; Ohashi Y; Masuda S; Sen Y; Komatsu F; Kataoka S; Fujita Y; Kamei Y; Yamamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Nov; 84(11):1961-8. PubMed ID: 8258931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of stage C prostatic carcinoma.
    Flocks RH; O'Donoghue EP; Millerman LA; Culp DA
    Urol Clin North Am; 1975 Feb; 2(1):163-79. PubMed ID: 1093058
    [No Abstract]   [Full Text] [Related]  

  • 37. The patient, disease status, and treatment options for prostate cancer: stages B1 and B2.
    Herr HW
    Prostate; 1983; 4(5):447-59. PubMed ID: 6889190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963.
    Jewett HJ
    J Urol; 1980 Oct; 124(4):492-4. PubMed ID: 7420591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease.
    Golimbu M; Schinella R; Morales P; Kurusu S
    J Urol; 1978 May; 119(5):618-22. PubMed ID: 660732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stage I prostatic cancer. Our therapeutic attitude].
    Bollack C; Levin G; Neidhardt J; Vetter JM; Vanegas M
    J Urol Nephrol (Paris); 1977; 83(1-2):99-103. PubMed ID: 875132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.